FDA Rejects Titan Drug for Opioid Dependence

FDA rejects Titan drug for opioid dependence
Filed under: Drug Abuse and Addiction
By Toni Clarke (Reuters) – U.S. health regulators rejected an experimental drug to treat opioid addiction made by Titan Pharmaceuticals Inc and asked for additional data showing it works, the company said. The drug, Probuphine, is a long-acting version of buprenorphine, a drug sold by British rival Reckitt-Benckiser Group Plc under the brand names Subutex and Suboxone. …
Source

House Call: Dealing with Addiction
Filed under: Drug Abuse and Addiction
According to the National Survey on Drug Use and Health, 22.6 million Americans have an alcohol or drug abuse problem….
Source

UPDATE 2-FDA rejects Titan drug for opioid dependence
Filed under: Drug Abuse and Addiction
U.S. health regulators rejected an experimental drug to treat opioid addiction made by Titan Pharmaceuticals Inc and asked for additional data showing it works, the company said. The drug, Probuphine, …
Source

Related Drug Abuse And Addiction Information…